BTIG Research Upgrades Endologix To Buy, Shares Gain
August 25, 2014 at 08:41 AM EDT
Analysts at BTIG Research upgraded Endologix (NASDAQ: ELGX) from Neutral to Buy. The target price for Endologix is set to $17. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|